Products And Services
Products And Services
Products and services
Products and services
Indication： This product is suitable to treat the symptoms and signs of Primary Parkinson’s disease in combination with levodopa.
Strength：0.5mg, 3mg (by ropinirole)
Package： Laminated film package, 30 tablets/carton
Validity：24 months
Approval number：0.5mg: National Medicine Standard H20130044
3mg: National Medicine Standard H20130045
The first generic drug consistency evaluation in China
- A new generation of selective ergot dopamine receptor agonists;
- It is recommended as first-line medication for early Parkinson’s treatment by the United States, European and Chinese Parkinson's guidelines.
- Its efficacy and safety are demonstrated by over-20-year clinical medication experience abroad.
- The incidence of dyskinesia in early Parkinson's patients is very low, and it can significantly delay the onset of dyskinesia.
-It assists L-dopa in the treatment of patients with advanced Parkinson’s disease. It can effectively shorten the “day off phenomenon” and reduce 20% of the usage amount of L-dopa.
微信公眾號